Browsing: Federal
Proposed Bipartisan Cancer Drug Parity Act Extends Treatment Protections for Privately Insured Cancer Patients
Legislation introduced by U.S. Congressmen Leonard Lance (R–N.J.) and Brian Higgins (D–N.Y.) would ensure that…
States May Bolster the Affordable Care Act by Enacting Individual Mandates
Recent legislative actions on Capitol Hill to repeal elements of the Affordable Care Act (ACA)…
FDA Commissioner Convenes Task Force to Prevent Drug Shortages Following Hurricane Maria
Earlier this week, Food and Drug Administration (FDA) Commissioner Scott Gottlieb established a task force…
FDA’s REMS Program Protects Women’s Health
The FDA’s Risk Evaluation and Mitigation Strategies (REMS) program ensures valuable medicines that would not…
Senate Passes Bill To Improve Treatments for Childhood Cancers
Yesterday, the Senate passed a bill requiring the pharmaceutical industry to study the safety and…
Aimed Alliance in Bloomberg: REMS Drug Program Keeps Patients Safe
Aimed Alliance Executive Director, Stacey Worthy, was quoted in a Bloomberg article discussing the U.S.…
Federal Proposal Allowing Importation of Foreign Drugs Could Harm Patients
A recent federal proposal that would allow importation of foreign drugs could risk the health…
Medicare Beneficiaries Receiving Observation Care Later Surprised by Hospital, Nursing Home Bills
Many Medicare beneficiaries are surprised by hospital and nursing home bills, finding out Medicare did…